Company Performance Metrics
Nikhil Phadke: Founder & Chief Scientific Officer
GenePath Dx is a diagnostics company, providing state-of-the-art in vitro diagnostic techniques such as molecular diagnostics to the medical, healthcare, and allied communities. It is committed to providing accurate and affordable diagnostics that are relevant and actionable. The company’s portfolio includes DNA and RNA based tests for Infectious
Diseases, Oncology, Endocrinology, Transplantation typing, Haematology, Pharmacogenetics, and Pre-natal and pre-implantation genetic diagnostics.
GenePath Dx uses advanced, but proven, platform technologies such as quantitative or real-time polymerase chain reaction, multiplex ligation-dependent probe amplification, and Sanger and Next Generation Sequencing. Its molecular tests are more rapid compared to conventional microbiology and more sensitive than immunology based tests. For an increasing number of conditions, it is the only way to carry out a diagnosis.
GenePath Dx is an innovation-centric company with an emphasis on continuous R&D. The company is constantly evolving in pace with global developments in the field and have the ability to develop new tests where needed. It was founded in 2012 by Nikhil Phadke and is headquartered in Pune, India.
